Physician counseling, informed consent and parental decision making for infants with hypoplastic left-heart syndrome

J J Paris1, M P Moore, M D Schreiber

  • 1SJ Walsh Professor of Bioethics, Boston College, Chestnut Hill, MA 02467, USA. john.paris@bc.edu

Insights

The Norwood procedure offers improved survival for hypoplastic left heart syndrome (HPLHS) but raises ethical concerns. Informed parental consent requires full disclosure of surgical risks and developmental outcomes.

Area of Science:

  • Pediatric Cardiology
  • Bioethics
  • Congenital Heart Disease

Background:

  • Hypoplastic Left Heart Syndrome (HPLHS) historically lacked treatment options.
  • The development of the Norwood procedure in 1980 revolutionized HPLHS management.
  • Current options include the Norwood procedure, transplantation, or comfort care.

Purpose of the Study:

  • To evaluate the ethical implications of treatment choices for HPLHS.
  • To examine the balance between improved survival rates and potential long-term impairments.
  • To emphasize the importance of informed consent in pediatric cardiac surgery.

Main Methods:

  • Review of historical treatment protocols for HPLHS.
  • Analysis of the evolution of the Norwood procedure's survival rates.
  • Ethical considerations of parental decision-making in complex congenital heart disease.

Main Results:

  • The Norwood procedure's survival rate has improved from 30% to over 80%.
  • Physicians debate discontinuing comfort care due to improved surgical outcomes.
  • Medically informed parents may still opt for comfort care, citing neurological and motor skill impairments.

Conclusions:

  • The two-pronged approach to HPLHS treatment raises questions of equity and fairness.
  • Comprehensive parental counseling on long-term outcomes is crucial for informed consent.
  • Balancing survival benefits with quality of life is essential in pediatric palliative care decisions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...